Santen Pharmaceutical Co (4536N) Q1 2024 Earnings Report
MX:4536N Q1 2024 EPS Results
- Actual EPS
- MXN 3.53
- Consensus EPS
- MXN 3.10
- Beat/Miss
- Beat by +MXN 0.43
- One Year Ago EPS
- MXN 3.33
MX:4536N Q1 2024 Revenue Results
- Actual Revenue
- MXN 8.91B
- Expected Revenue
- MXN 8.97B
- Beat/Miss
- Missed by -MXN 55.64M
- YoY Revenue Growth
- +3.29%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 08/06/2024
- Time
- TBA
- Conference Call
- Tuesday, August 6, 2024
MX:4536N Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q1 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4536N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q2) | 3.72- | 2.91 | ― | ― |
| Aug 06, 2026 | 2026 (Q1) | 2.542.67 | 2.07 | 29.21% (+0.60) | |
| May 12, 2026 | 2025 (Q4) | 3.675.71 | 3.07 | 85.80% (+2.64) | |
| Feb 05, 2026 | 2025 (Q3) | 3.492.91 | 3.02 | -3.67% (-0.11) | |
| Nov 06, 2025 | 2025 (Q2) | 2.492.91 | 2.78 | 4.94% (+0.14) | |
| Aug 07, 2025 | 2025 (Q1) | 2.852.07 | 3.53 | -41.47% (-1.46) | |
| May 13, 2025 | 2024 (Q4) | 2.063.07 | 1.95 | 57.30% (+1.12) | |
| Feb 06, 2025 | 2024 (Q3) | 3.113.02 | 2.41 | 25.40% (+0.61) | |
| Nov 07, 2024 | 2024 (Q2) | 2.592.78 | 2.88 | -3.48% (-0.10) | |
| Aug 06, 2024 | 2024 (Q1) | 3.103.53 | 3.33 | 5.94% (+0.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed